Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2Gastrointestinal 2Lymphoid 1CNS 1

Conditions

Lung Neoplasms 2

Interventions

Carboplatin 182pembrolizumab 157Pemetrexed 132Cisplatin 98Drug Therapy 68Paclitaxel 61osimertinib 55Nivolumab 50Magnetic Resonance Spectroscopy 50Specimen Handling 49durvalumab 48Radiotherapy 48Docetaxel 44atezolizumab 43Etoposide 40Bevacizumab 39tislelizumab 33Blood Specimen Collection 33Radiosurgery 31Gemcitabine 29130-nm albumin-bound paclitaxel 28Immunotherapy 26Immune Checkpoint Inhibitors 24cemiplimab 23Injections 22aflutinib 20Cetuximab 19Biopsy 18Platinum Compounds 17Surgical Procedures, Operative 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × High-Intensity Interval Training × Thoracic × Clear all
NCT06026111 2026-04-14

ENHANCE

Dana-Farber Cancer Institute

Phase NA Recruiting
30 enrolled
Thoracic

Lung Neoplasms

NCT06215326 2024-03-01

PRE-EXELUCA

Guangdong Provincial People's Hospital

Phase NA Recruiting
100 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡